| No headlines available for CMVAX. |
|
|
| Morningstar Overall Rating: |
 |
| Total Assets: |
43.16M |
| Category: |
Mid-Cap Blend |
| Total Expense Ratio: |
1.59% |
|
| PERFORMANCE & RISK | 31-Dec-07
| YTD Return: |
0.80% |
| 5y Avg Return: |
N/A |
| Rank in Category (ytd): |
355 |
| % Rank in Category (ytd): |
71.86% |
| Beta (3y): |
0.95 |
| Morningstar Risk Rating: |
Below average |
|
| The investment seeks long-term capital appreciation. The fund normally invests at least 80% of assets in the common stocks of mid-size companies that are within the range of market capitalizations of the Russell MidCap Value index. It seeks to have a weighted average market capitalization of between $2 and $10 billion. All investments are selected on the basis of their ability to contribute to the dual objectives of financial soundness and societal impact. The fund may also invest up to 25% of net assets in foreign securities. |
|
| Fund Profile
- CMVAX Prospectus
|
|